US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VERICI DX PLC

0.0030

0.0000

Volume:- -

Turnover:- -

Market Cap:4.54M

PE:-0.12

High:0.0030

Open:0.0030

Low:0.0030

Close:0.0030

52wk High:0.0300

52wk Low:0.0030

Shares:1.51B

Float Shares:1.07B

Volume Ratio:0.70

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0245

EPS(LYR):-0.0513

ROE:-123.41%

ROA:-57.94%

PB:1.83

PE(LYR):-0.06

Loading ...

Overview Company News Filings

Company Profile

Company Name:

VERICI DX PLC

Exchange:

PINK LIMITED

Establishment Date:

2020

Employees:

15

Office Location:

Avon House,19 Stanwell Road,Penarth,Cardiff,South Glamorgan,United Kingdom

Website:

http://www.vericidx.com

Zip Code:

CF64 2EZ

Phone:

- -

Fax:

- -

Introduction:

Verici Dx plc develops prognostic and diagnostic tests for kidney transplant patients. Its lead products are Tutivia, a post-transplant diagnostic test focused on acute cellular rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection. The company is also developing Protega, a liquid biopsy to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Cardiff, the United Kingdom.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VRCDF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRCDF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRCDF\",,,,,undefined,":{"symbol":"VRCDF","market":"US","secType":"STK","nameCN":"VERICI DX PLC","latestPrice":0.003,"timestamp":1770843600000,"preClose":0.003,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":1074141772,"shares":1513394127,"eps":-0.024478,"marketStatus":"Pre-Mkt","change":0,"latestTime":"02-11 16:00:00 EST Delay","open":0.003,"high":0.003,"low":0.003,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.024478,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770906600000},"marketStatusCode":1,"adr":0,"exchange":"PINK LIMITED","adjPreClose":0.003,"volumeRatio":0.7001855866361695},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRCDF\",,,,,undefined,":{"symbol":"VRCDF","floatShares":1074141772,"roa":"-57.94%","roe":"-123.41%","lyrEps":-0.05128,"volumeRatio":0.7001855866361695,"shares":1513394127,"dividePrice":0,"high":0.003,"amplitude":0,"preClose":0.003,"low":0.003,"week52Low":0.003,"pbRate":"1.83","psRate":"2.37","week52High":0.03,"institutionHeld":0,"latestPrice":0.003,"eps":-0.024478,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.024478,"open":0.003,"prevYearClose":0.003,"prevWeekClose":0.003,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.003,"twentyDayClose":0.003,"sixtyDayClose":0.0076},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRCDF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-30","symbol":"VRCDF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1717041600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRCDF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRCDF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1755666000000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":665800941,"yearFounded":2020,"employeeNum":15,"address":"Avon House,19 Stanwell Road,Penarth,Cardiff,South Glamorgan,United Kingdom","zipCode":"CF64 2EZ"},"stockCompanyDetail":{"websiteUrl":"http://www.vericidx.com","description":"Verici Dx plc develops prognostic and diagnostic tests for kidney transplant patients. Its lead products are Tutivia, a post-transplant diagnostic test focused on acute cellular rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection. The company is also developing Protega, a liquid biopsy to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Cardiff, the United Kingdom.","exchange":"PINK LIMITED","name":"VERICI DX PLC","nameEN":"VERICI DX PLC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VRCDF\",market:\"US\",,,undefined,":null}}